Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 258.75 USD -0.58% Market Closed
Market Cap: 18.2B USD

During the last 3 months Insulet Corp insiders have not bought any shares, and sold 4m USD worth of shares. The stock price has dropped by 1% over this period (open performance analysis).

The last transaction was made on Mar 25, 2025 by Frederick Wayne A.i. (Chief Human Resources Officer) , who sold 501.9k USD worth of PODD shares.

Last Transactions:
Frederick Wayne A.i.
Chief Human Resources Officer
$-501.9k
Benjamin Eric
Chief Operating Officer
$-3.5m
Benjamin Eric
Chief Operating Officer
$-1.2m
Budden Lauren
Chief Operating Officer
$-252.2k
Hopfield Jessica
Chairman of the Board
$-1.7m
Scannell Timothy J
Executive Vice President and President of MedSurg, Orthopaedics and Spine
$-1.1m
Field Mark N
Executive Vice President and Chief Commercial Officer
$-305.5k
Budden Lauren
Chief Operating Officer
$-333.4k
Singh Prem
Senior Vice President and Chief Commercial Officer
$-368.9k
Chadwick Ana Maria
Chief Financial Officer
$+20.6k
Field Mark N
Executive Vice President and Chief Commercial Officer
$-281.6k
Field Mark N
Executive Vice President and Chief Commercial Officer
$-299.9k
Scannell Timothy J
Executive Vice President and President of MedSurg, Orthopaedics and Spine
$-1.3m
Field Mark N
Executive Vice President and Chief Commercial Officer
$-405.8k
Borio Luciana
Chief Operating Officer
$-65.7k
Scannell Timothy J
Executive Vice President and President of MedSurg, Orthopaedics and Spine
$-597k
Petrovic Shacey
Executive Vice President and President of Europe, Middle East, and Africa (EMEA)
$-1.9m
Borio Luciana
Chief Operating Officer
$-14.9k
Petrovic Shacey
Executive Vice President and President of Europe, Middle East, and Africa (EMEA)
$-342.4k
Singh Prem
Senior Vice President and Chief Commercial Officer
$+168.9
Hollingshead James
President and Chief Executive Officer
$+1m
Mcmillan Wayde D.
Director
$-392.7k
Manea Dan
Chief Operating Officer
$-50.8k
Borio Luciana
Chief Operating Officer
$-141.7k
Petrovic Shacey
Executive Vice President and President of Europe, Middle East, and Africa (EMEA)
$-4.1m
Minogue Michael R
Chairman, President & Chief Executive Officer
$+1m
Mcmillan Wayde D.
Director
$-399.5k
Alpuche Charles
Chief Operating Officer
$-7.1m
Alpuche Charles
Chief Operating Officer
$-1.2m
Petrovic Shacey
Executive Vice President and President of Europe, Middle East, and Africa (EMEA)
$-4.1m
Alpuche Charles
Chief Operating Officer
$-1.1m
Petrovic Shacey
Executive Vice President and President of Europe, Middle East, and Africa (EMEA)
$-4.2m
View All Transactions

During the last 3 months Insulet Corp insiders have not bought any shares, and sold 4m USD worth of shares. The stock price has dropped by 1% over this period (open performance analysis).

The last transaction was made on Mar 25, 2025 by Frederick Wayne A.i. (Chief Human Resources Officer) , who sold 501.9k USD worth of PODD shares.

Sold
0-3
months
4m USD
2
3-6
months
1.4m USD
2
6-9
months
4.1m USD
5
9-12
months
2.7m USD
3
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
1
20.6k USD
9-12
months
0
0 USD

Insulet Corp
Insider Trading Chart

Insulet Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Insulet Corp
Last Insider Transactions

Global
Insiders Monitor

Insulet Corp
Glance View

Economic Moat
Narrow
Market Cap
18.2B USD
Industry
Health Care

Insulet Corporation has carved out a significant niche in the medical device industry, distinguishing itself through its innovative approach to diabetes management. The company is best known for its Omnipod Insulin Management System, a discreet, tubeless insulin pump that provides a solution for individuals with diabetes seeking an alternative to traditional insulin delivery methods. Unlike conventional pumps that require cumbersome tubes and significant patient involvement, the Omnipod system offers ease and convenience, allowing users more freedom and flexibility in their daily lives. The system operates via a small wearable pod that delivers insulin over several days, which users control remotely, removing much of the hassle associated with managing diabetes. Insulet generates revenue by selling these pods and the associated Personal Diabetes Manager (PDM) devices, which together comprise the entire system. Customers typically purchase pods on a recurring basis, similar to a subscription model, which creates a steady stream of revenue for the company. The business model emphasizes continuous growth by expanding its user base and improving its technology to remain at the forefront of patient-centric diabetes care. Insulet's strategic focus on the needs of its users and commitment to refining their health technology has enabled it to build a sustainable business that addresses a critical healthcare challenge while also delivering consistent financial performance.

PODD Intrinsic Value
122.99 USD
Overvaluation 52%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top